These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 33354901)

  • 1. Prevalence and prognostic value of autonomic neuropathy assessed by Sudoscan® in transthyretin wild-type cardiac amyloidosis.
    Kharoubi M; Roche F; Bézard M; Hupin D; Silva S; Oghina S; Chalard C; Zaroui A; Galat A; Guendouz S; Canoui-Poitrine F; Hittinger L; Teiger E; Lefaucheur JP; Damy T
    ESC Heart Fail; 2021 Apr; 8(2):1656-1665. PubMed ID: 33354901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left ventricular structure and function in transthyretin-related versus light-chain cardiac amyloidosis.
    Quarta CC; Solomon SD; Uraizee I; Kruger J; Longhi S; Ferlito M; Gagliardi C; Milandri A; Rapezzi C; Falk RH
    Circulation; 2014 May; 129(18):1840-9. PubMed ID: 24563469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral nerve involvement in wild-type transthyretin amyloidosis.
    Campagnolo M; Cacciavillani M; Cipriani A; Salvalaggio A; Castellani F; Pilichou K; Briani C
    Neurol Sci; 2023 Jan; 44(1):351-354. PubMed ID: 36260260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Same same, but different? The neurological presentation of wildtype transthyretin (ATTRwt) amyloidosis.
    Kleefeld F; Scherret E; Knebel F; Messroghli D; Heidecker B; Wetz C; Schatka I; Barzen G; Tschöpe C; Amthauer H; Hahn K
    Amyloid; 2022 Jun; 29(2):92-101. PubMed ID: 34994254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variation of the transthyretin gene in wild-type transthyretin amyloidosis (ATTRwt).
    Sikora JL; Logue MW; Chan GG; Spencer BH; Prokaeva TB; Baldwin CT; Seldin DC; Connors LH
    Hum Genet; 2015 Jan; 134(1):111-21. PubMed ID: 25367359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Senile systemic amyloidosis: clinical features at presentation and outcome.
    Pinney JH; Whelan CJ; Petrie A; Dungu J; Banypersad SM; Sattianayagam P; Wechalekar A; Gibbs SD; Venner CP; Wassef N; McCarthy CA; Gilbertson JA; Rowczenio D; Hawkins PN; Gillmore JD; Lachmann HJ
    J Am Heart Assoc; 2013 Apr; 2(2):e000098. PubMed ID: 23608605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of left atrial strain in patients with wild-type transthyretin amyloid cardiomyopathy.
    Oike F; Usuku H; Yamamoto E; Yamada T; Egashira K; Morioka M; Nishi M; Komorita T; Hirakawa K; Tabata N; Yamanaga K; Fujisue K; Hanatani S; Sueta D; Arima Y; Araki S; Takashio S; Oda S; Misumi Y; Kawano H; Matsushita K; Ueda M; Matsui H; Tsujita K
    ESC Heart Fail; 2021 Dec; 8(6):5316-5326. PubMed ID: 34582129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of wild-type transthyretin cardiac amyloidosis in patients with carpal tunnel syndrome surgery (CACTuS).
    Ladefoged B; Clemmensen T; Dybro A; Hartig-Andreasen C; Kirkeby L; Gormsen LC; Bomholt P; Gillmore J; Poulsen SH
    ESC Heart Fail; 2023 Feb; 10(1):234-244. PubMed ID: 36193570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced trans-mitral A-wave velocity predicts the presence of wild-type transthyretin amyloidosis in elderly patients with left ventricular hypertrophy.
    Yamamura S; Izumiya Y; Ishida T; Onoue Y; Kimura Y; Hanatani S; Araki S; Fujisue K; Sueta D; Kanazawa H; Takashio S; Usuku H; Sugamura K; Sakamoto K; Yamamoto E; Yamamuro M; Yasuda H; Kojima S; Kaikita K; Hokimoto S; Ogawa H; Tsujita K
    Heart Vessels; 2017 Jun; 32(6):708-713. PubMed ID: 27882404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction.
    González-López E; Gallego-Delgado M; Guzzo-Merello G; de Haro-Del Moral FJ; Cobo-Marcos M; Robles C; Bornstein B; Salas C; Lara-Pezzi E; Alonso-Pulpon L; Garcia-Pavia P
    Eur Heart J; 2015 Oct; 36(38):2585-94. PubMed ID: 26224076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of Ventilatory Efficiency Slope as a Marker for Increased Mortality in Wild-Type Transthyretin Cardiac Amyloidosis.
    Yunis A; Doros G; Luptak I; Connors LH; Sam F
    Am J Cardiol; 2019 Jul; 124(1):122-130. PubMed ID: 31053293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Features of atrial fibrillation in wild-type transthyretin cardiac amyloidosis: a systematic review and clinical experience.
    Mints YY; Doros G; Berk JL; Connors LH; Ruberg FL
    ESC Heart Fail; 2018 Oct; 5(5):772-779. PubMed ID: 29916559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determining patterns of vascular function and structure in wild-type transthyretin cardiac amyloidosis. A comparative study.
    Stamatelopoulos K; Delialis D; Georgiopoulos G; Tselegkidi MI; Theodorakakou F; Dialoupi I; Bambatsias D; Petropoulos I; Vergaro G; Ikonomidis I; Tzortzis S; Briasoulis A; Kanakakis J; Trougakos I; Dimopoulos MA; Kastritis E
    Int J Cardiol; 2022 Sep; 363():102-110. PubMed ID: 35716935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics and natural history of wild-type transthyretin amyloid cardiomyopathy in Japan.
    Yamada T; Takashio S; Arima Y; Nishi M; Morioka M; Hirakawa K; Hanatani S; Fujisue K; Yamanaga K; Kanazawa H; Sueta D; Araki S; Usuku H; Nakamura T; Suzuki S; Yamamoto E; Ueda M; Kaikita K; Tsujita K
    ESC Heart Fail; 2020 Oct; 7(5):2829-2837. PubMed ID: 32672425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of Longitudinal Strain to Identify Wild-Type Transthyretin Amyloidosis in Patients With Aortic Stenosis.
    Robin G; Cognet T; Bouisset F; Cariou E; Méjean S; Pradel S; Colombat M; Galinier M; Carrié D; Lairez O;
    Circ J; 2021 Aug; 85(9):1494-1504. PubMed ID: 33980765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early Experience of Tafamidis Treatment in Japanese Patients With Wild-Type Transthyretin Cardiac Amyloidosis From the Kochi Amyloidosis Cohort.
    Ochi Y; Kubo T; Baba Y; Sugiura K; Miyagawa K; Noguchi T; Hirota T; Hamada T; Yamasaki N; Kitaoka H
    Circ J; 2022 Jun; 86(7):1121-1128. PubMed ID: 35599003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of cardiac amyloidosis among elderly patients with systolic heart failure or conduction disorders.
    López-Sainz Á; de Haro-Del Moral FJ; Dominguez F; Restrepo-Cordoba A; Amor-Salamanca A; Hernandez-Hernandez A; Ruiz-Guerrero L; Krsnik I; Cobo-Marcos M; Castro V; Toquero-Ramos J; Lara-Pezzi E; Fernandez-Lozano I; Alonso-Pulpon L; González-López E; Garcia-Pavia P
    Amyloid; 2019 Sep; 26(3):156-163. PubMed ID: 31210553
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical and apparative investigation of large and small nerve fiber impairment in mixed cohort of ATTR-amyloidosis: impact on patient management and new insights in wild-type.
    Papagianni A; Ihne S; Zeller D; Morbach C; Üçeyler N; Sommer C
    Amyloid; 2022 Mar; 29(1):14-22. PubMed ID: 34632904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac Amyloidosis: Overlooked, Underappreciated, and Treatable.
    Rubin J; Maurer MS
    Annu Rev Med; 2020 Jan; 71():203-219. PubMed ID: 31986086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of quantitative
    Ogasawara K; Shiraishi S; Tsuda N; Sakamoto F; Oda S; Takashio S; Tsujita K; Hirai T
    Jpn J Radiol; 2022 May; 40(5):508-517. PubMed ID: 34973114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.